Exact Sciences(EXAS) - 2025 Q3 - Quarterly Results

Steph Spanos Exact Sciences Corp. sspanos@exactsciences.com 608-556-4380 For Immediate Release Exact Sciences Announces Third Quarter 2025 Results Reports record revenue, raises full-year guidance, generates record cash from operations EXHIBIT 99.1 Investor Contact: Derek Leckow Exact Sciences Corp. investorrelations@exactsciences.com 608-893-0009 Media Contact: Third quarter and recent highlights MADISON, Wis., November 3, 2025 — Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening a ...